Elekta AB

Rank#4990

Market Cap1.91B

CountrySweden

Summary

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

History

Elekta was jointly founded in 1972 by the late Lars Leksell, Professor of Neurosurgery at the Karolinska Institute in Stockholm, Sweden, and his son Laurent Leksell, in order to commercialize the development of the Leksell Stereotactic System, and Gamma Knife, which he had been researching since the late 1940s.Since 1994, the company has been listed on the Nordic Exchange under the ticker EKTAb. Larry Leksell became Chief Executive Officer of Elekta until 2005, and under his leadership the company expanded into a public medical technology group with more than 3,400 employees worldwide. Larry Leksell remains the Chairman of the Board of Elekta. The role of President and CEO has been held by the following:

Tomas Puusepp: May 2005 to May 2014

Niklas Savander: May 2014 to May 2015

Tomas Puusepp: May 2015 to June 2016

Richard Hausmann: June 2016 until June 2020

Gustaf Salford: June–November 2020 ; November 2020 - today

Acquired companies

Elekta has acquired companies within the industry as well as distributors and service providers. Some of these include: Philips Medical Systems radiotherapy division, IMPAC Medical Systems, Inc., Beijing Medical Equipment Institute , 3D Line Medical Systems, CMS, Inc., Nucletron, ProKnow Systems, LLC, Kaiku Health.

Mission

Our mission is to improve patient lives by working together with our customers. We use our precision radiation expertise to work hand in hand with clinicians and our partners to continuously develop innovative, outcome-driven and cost-efficient solutions that provide lasting clinical difference. We believe in taking an open and proactive approach in our practices, enabling us to build strong partnerships and meet evolving patient needs, no matter where they are in the world. We don’t just build technology; we build hope.

Vision

A world where everyone has access to the best cancer care.

References

https://en.wikipedia.org/wiki/Elekta

https://in.investing.com/equities/elekta

https://finance.yahoo.com/quote/EKTA-B.ST/profile?p=EKTA-B.ST

https://www.comparably.com/companies/elekta/mission

https://www.crunchbase.com/organization/elekta-ab

https://companiesmarketcap.com/

https://www.elekta.com

Leadership team

Dr. Laurent Leksell (Founder & Chairman)